에이프릴바이오
₩18,110
▲ +280.00
(+1.57%)
Volume: 67,857
· 2026-09-23
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
43
- 21d momentum -7.0%
- RSI 41
🎯
Pullback
50
- +2.1% vs 20MA
💎
Value
58
- ROE 0.2%
- -76% off 52w high
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)41.5
MACD+478
MA trendMixed
ATR6.73%
21d mom.-7.0%
63d mom.-54.4%
vs 20MA+2.1%
RVOL(20)0.35×
52w low · 16,450
52w high · 76,700
-76.4% from 52-week high
20d support 16,450
· resistance 19,660
Computed live from daily OHLCV · as of 2026-09-23
🏦 Fundamentals
ROE0.2%
Op. margin—
Net margin—
FY2026
| Year | Revenue | Op. income | Op. margin |
|---|---|---|---|
| 2023 | — | -0.0T | — |
| 2024 | — | 0.0T | — |
| 2025 | — | -0.0T | — |
| 2026 | — | -0.0T | — |
From DART financial statements (KRW). Annual (or latest reported quarter).
⚖️ AI Bull vs Bear
14d momentum +7.99%, daily vol 4.47%. 에이프릴바이오 sits in a bullish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.
🏦 Investor Flow
Foreign
+0억
Institution
+1억
Retail
-1억
| Date | Foreign | Inst. | Retail |
|---|---|---|---|
| 09-23 | +0 | +1 | -1 |
| 09-22 | -4 | -1 | +6 |
| 09-21 | -4 | +8 | -5 |
| 09-18 | -8 | +12 | -4 |
| 09-17 | -4 | +5 | -1 |
Net buy/sell in ₩100M (억). Positive = net buying.